Literature DB >> 25903763

The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.

C Di Lorenzo1, G Coppola2, G Di Lorenzo3, M Bracaglia4, P Rossi5, F Pierelli6.   

Abstract

BACKGROUND: Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment.
METHODS: We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances.
RESULTS: Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). DISCUSSION: Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients. © International Headache Society 2015.

Entities:  

Keywords:  Cluster headache; LSA; LSD; illicit drugs; psilocybin

Mesh:

Substances:

Year:  2015        PMID: 25903763     DOI: 10.1177/0333102415583145

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

1.  Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

Authors:  Simon D Brandt; Pierce V Kavanagh; Geraldine Dowling; Brian Talbot; Folker Westphal; Markus R Meyer; Hans H Maurer; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-04-21       Impact factor: 3.345

Review 2.  Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Authors:  Emmanuelle A D Schindler
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  O036. Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review.

Authors:  Luisa Fofi; Valerio Orlandi; Nicola Vanacore; Maria C Mizzoni; Alba Rosa; Cinzia Aurilia; Gabriella Egeo; Pietro Casella; Piero Barbanti
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

4.  Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.

Authors:  Martin Andersson; Mari Persson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2017-09-05

Review 5.  Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.

Authors:  Yara Mouhamed; Andrey Vishnyakov; Bessi Qorri; Manpreet Sambi; Sm Signy Frank; Catherine Nowierski; Anmol Lamba; Umrao Bhatti; Myron R Szewczuk
Journal:  Drug Healthc Patient Saf       Date:  2018-06-11

Review 6.  Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review.

Authors:  David W Dodick; Peter J Goadsby; Messoud Ashina; Cristina Tassorelli; Hans-Peter Hundemer; Jennifer N Bardos; Richard Wenzel Md; Phebe Kemmer; Robert Conley; James M Martinez; Tina Oakes
Journal:  Headache       Date:  2022-04-01       Impact factor: 5.311

Review 7.  Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.

Authors:  Sakari Santeri Rusanen; Suchetana De; Emmanuelle Andree Danielle Schindler; Ville Aleksi Artto; Markus Storvik
Journal:  Curr Pain Headache Rep       Date:  2022-06-27

8.  Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial.

Authors:  Cherubino Di Lorenzo; Gianluca Coppola; Davide Di Lenola; Maurizio Evangelista; Giulio Sirianni; Paolo Rossi; Giorgio Di Lorenzo; Mariano Serrao; Francesco Pierelli
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

9.  Increased use of illicit drugs in a Dutch cluster headache population.

Authors:  Ilse F de Coo; Willemijn C Naber; Leopoldine A Wilbrink; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  Cephalalgia       Date:  2018-10-05       Impact factor: 6.292

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.